NEWAMSTERDAM PHARMA CO NV
NAMSNASDAQ🏆 #1431 by market capEarnings Nov 3 · PreUS Equity
$27.72▲ $0.09 (+0.34%)
Live1h▲ 0.5%
24h▲ 0.3%
7d▲ 1.1%
14d▼ 0.6%
30d▼ 16.7%
1y▲ 10.8%
🏦Market Cap
$3.24B
Small Cap
📈Revenue Growth (YoY)
-88.9%
Declining
📊Gross Margin
—
💵FCF Margin
1648.5%
Strong
⚖️P/S Ratio
469.7x
Expensive
Otter Score
65
Fair
📊
Analyst Ratings
Price
$27.72
Total
10
Raised
0
Lowered
0
Avg PT
$49.75
H / L
$58 / $45
| Institution | Action | Rating | Date |
|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-06-30 |
Guggenheim | Reiterated | Buy | 2026-02-19 |
Needham | Reiterated | Buy | 2026-02-18 |
Stifel | Reiterated | Buy | 2025-12-16 |
Goldman Sachs | Reiterated | Neutral | 2025-12-02 |
Citigroup | Reiterated | Buy | 2025-10-17 |
Scotiabank | Reiterated | Sector Outperform | 2025-02-27 |
HC Wainwright & Co. | Reiterated | Buy | 2025-01-14 |
Piper Sandler | Reiterated | Overweight | 2024-09-23 |
Credit Suisse | Reiterated | Outperform | 2023-04-03 |
One row per institution, most recent rating